• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donors.

作者信息

Lindemann M, Koldehoff M, Fiedler M, Schumann A, Ottinger H D, Heinemann F M, Roggendorf M, Horn P A, Beelen D W

机构信息

Institute for Transfusion Medicine, University Hospital, Essen, Germany.

Department of Bone Marrow Transplantation, University Hospital, Essen, Germany.

出版信息

Bone Marrow Transplant. 2016 Mar;51(3):428-31. doi: 10.1038/bmt.2015.253. Epub 2015 Oct 26.

DOI:10.1038/bmt.2015.253
PMID:26501767
Abstract
摘要

相似文献

1
Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donors.
Bone Marrow Transplant. 2016 Mar;51(3):428-31. doi: 10.1038/bmt.2015.253. Epub 2015 Oct 26.
2
Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.对已治愈乙型肝炎的造血干细胞接受者进行长期监测：即使供者已接种疫苗，接受者仍有较高的病毒再激活风险。
J Viral Hepat. 2007 Jul;14(7):478-83. doi: 10.1111/j.1365-2893.2006.00830.x.
3
[Hepatitis B virus reactivation in patients with HBs antibodies after allogeneic hematopoietic stem cell transplantation].异基因造血干细胞移植后HBs抗体阳性患者的乙型肝炎病毒再激活
Rinsho Ketsueki. 2007 May;48(5):386-90.
4
HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection.乙型肝炎疫苗接种预防既往感染过乙肝病毒的异基因造血干细胞移植受者的病毒再激活
Biol Blood Marrow Transplant. 2008 Nov;14(11):1226-30. doi: 10.1016/j.bbmt.2008.08.007.
5
Prevention of hepatitis B virus transmission from an infected stem cell donor.
Bone Marrow Transplant. 2007 Aug;40(4):399-400. doi: 10.1038/sj.bmt.1705740. Epub 2007 Jun 18.
6
Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab.拉米夫定对接受阿仑单抗进行减低剂量预处理造血干细胞移植的乙肝病毒暴露受者的预防和治疗作用
J Med Virol. 2006 Dec;78(12):1560-3. doi: 10.1002/jmv.20705.
7
[Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].[异基因造血干细胞移植后乙型肝炎血清学标志物的变化]
Korean J Hepatol. 2009 Jun;15(2):131-9. doi: 10.3350/kjhep.2009.15.2.131.
8
Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.长期拉米夫定单药治疗可预防乙肝核心抗体阳性供体的乙肝表面抗原阴性肝移植受者发生乙肝病毒感染。
Clin Transplant. 2006 May-Jun;20(3):369-73. doi: 10.1111/j.1399-0012.2006.00495.x.
9
[Hematopoietic stem cell transplantation in patients or from donors with hepatitis B or C virus infection:review and recommendations].[乙肝或丙肝病毒感染患者或供体的造血干细胞移植：综述与建议]
Med Clin (Barc). 2002 Mar 2;118(7):268-77.
10
Emergence of YMDD mutant hepatitis B virus after allogeneic stem cell transplantation from a HBsAG-positive donor during lamivudine prophylaxis.在拉米夫定预防期间，接受来自HBsAg阳性供体的异基因干细胞移植后出现YMDD突变型乙型肝炎病毒。
Haematologica. 2004 Apr;89(4):ECR09.

引用本文的文献

1
[Chinese expert consensus on prevention of hepatitis B virus reactivation after allogeneic hematopoietic stem cell transplantation (2023)].《中国异基因造血干细胞移植后乙肝病毒再激活防治专家共识（2023年版）》
Zhonghua Xue Ye Xue Za Zhi. 2023 Jun 14;44(6):441-448. doi: 10.3760/cma.j.issn.0253-2727.2023.06.001.
2
Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.接受异基因造血干细胞移植患者的乙型肝炎病毒感染
J Pers Med. 2021 Oct 28;11(11):1108. doi: 10.3390/jpm11111108.
3
Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation.

本文引用的文献

1
Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection?异基因干细胞移植供者和受者的移植前疫苗接种：免疫保护中一个常被错过的机会？
Bone Marrow Transplant. 2015 Jul;50(7):899-903. doi: 10.1038/bmt.2015.49. Epub 2015 Mar 23.
2
Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.通过接种前S1/前S2/S疫苗增强对乙肝疫苗的免疫反应。
Med Microbiol Immunol. 2015 Feb;204(1):57-68. doi: 10.1007/s00430-014-0374-x. Epub 2015 Jan 4.
3
Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients.
异基因造血干细胞移植中乙型肝炎病毒的管理。
Front Immunol. 2021 Feb 4;11:610500. doi: 10.3389/fimmu.2020.610500. eCollection 2020.
4
Humanized anti-CD19 chimeric antigen receptor-T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved hepatitis B virus infection.嵌合抗原受体-T 细胞治疗人源化抗 CD19 对慢性和已解决乙型肝炎病毒感染的淋巴瘤和白血病患者安全且有效。
Hematol Oncol. 2021 Feb;39(1):75-86. doi: 10.1002/hon.2807. Epub 2020 Oct 1.
5
Immunological Analysis of the Hepatitis B Virus "a" Determinant Displayed on Chimeric Virus-Like Particles of Nodavirus Capsid Protein Produced in 9 Cells.对在9细胞中产生的诺达病毒衣壳蛋白嵌合病毒样颗粒上展示的乙型肝炎病毒“a”决定簇的免疫学分析。
Vaccines (Basel). 2020 Jun 4;8(2):275. doi: 10.3390/vaccines8020275.
6
HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review.造血干细胞移植患者中乙型肝炎病毒再激活：一篇叙述性综述。
Viruses. 2019 Nov 10;11(11):1049. doi: 10.3390/v11111049.
7
Reactivation of hepatitis B virus infection in patients with hematologic disorders.血液系统疾病患者乙型肝炎病毒再激活。
Haematologica. 2019 Mar;104(3):435-443. doi: 10.3324/haematol.2018.210252. Epub 2019 Feb 7.
8
Humoral immunity, the underestimated player in hepatitis B.体液免疫，乙型肝炎中被低估的因素。
Cell Mol Immunol. 2018 Jun;15(6):645-648. doi: 10.1038/cmi.2017.132. Epub 2017 Dec 11.
将来自免疫的活体肝脏供体的乙肝病毒特异性免疫进行过继性免疫转移至肝脏受体。
Transplantation. 2009 Jan 15;87(1):103-11. doi: 10.1097/TP.0b013e31818bfc85.
4
Cellular and humoral immune response to a third generation hepatitis B vaccine.对第三代乙肝疫苗的细胞免疫和体液免疫反应
J Viral Hepat. 2007 Aug;14(8):592-8. doi: 10.1111/j.1365-2893.2007.00848.x.
5
Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.对已治愈乙型肝炎的造血干细胞接受者进行长期监测：即使供者已接种疫苗，接受者仍有较高的病毒再激活风险。
J Viral Hepat. 2007 Jul;14(7):478-83. doi: 10.1111/j.1365-2893.2006.00830.x.
6
Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection.
Transplantation. 2005 Mar 15;79(5):616-9. doi: 10.1097/01.tp.0000151661.52601.fb.
7
Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation.异基因外周血干细胞移植受者和供者的乙型肝炎病毒疫苗接种。
Clin Transplant. 2003 Oct;17(5):438-43. doi: 10.1034/j.1399-0012.2003.00070.x.
8
Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation.造血细胞移植前供体疫苗接种以及移植前和移植后早期受体疫苗接种的效果。
Bone Marrow Transplant. 2004 Feb;33(3):337-46. doi: 10.1038/sj.bmt.1704336.
9
Transfer of humoral and cellular hepatitis B immunity by allogeneic hematopoietic cell transplantation.
Transplantation. 2003 Mar 27;75(6):833-8. doi: 10.1097/01.TP.0000054841.42796.68.
10
Role of G protein beta3 subunit C825T and HLA class II polymorphisms in the immune response after HBV vaccination.G蛋白β3亚基C825T多态性和人类白细胞抗原II类基因多态性在乙肝疫苗接种后免疫反应中的作用
Virology. 2002 Jun 5;297(2):245-52. doi: 10.1006/viro.2002.1467.